메뉴 건너뛰기




Volumn 154, Issue 5, 2011, Pages 654-656

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies

Author keywords

Combination; Deferasirox; Deferiprone; Iron chelation; Thalassemia

Indexed keywords

CREATININE; CYSTATIN C; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN;

EID: 80955178788     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08626.x     Document Type: Letter
Times cited : (45)

References (10)
  • 1
    • 77953069934 scopus 로고    scopus 로고
    • Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients
    • Balocco, M., Carrara, P., Pinto, V. & Forni, G.L. (2010) Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients. American Journal of Hematology, 85, 460-461.
    • (2010) American Journal of Hematology , vol.85 , pp. 460-461
    • Balocco, M.1    Carrara, P.2    Pinto, V.3    Forni, G.L.4
  • 3
    • 34548708556 scopus 로고    scopus 로고
    • Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review
    • Delea, T.E., Edelsberg, J., Sofrygin, O., Thomas, S.K., Baladi, J.F., Phatak, P.D. & Coates, T.D. (2007) Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion, 47, 1919-1929.
    • (2007) Transfusion , vol.47 , pp. 1919-1929
    • Delea, T.E.1    Edelsberg, J.2    Sofrygin, O.3    Thomas, S.K.4    Baladi, J.F.5    Phatak, P.D.6    Coates, T.D.7
  • 4
    • 74049116227 scopus 로고    scopus 로고
    • Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
    • Farmaki, K., Tzoumari, I., Pappa, C., Chouliaras, G. & Berdoukas, V. (2010) Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. British Journal of Haematology, 148, 466-475.
    • (2010) British Journal of Haematology , vol.148 , pp. 466-475
    • Farmaki, K.1    Tzoumari, I.2    Pappa, C.3    Chouliaras, G.4    Berdoukas, V.5
  • 6
    • 77955891235 scopus 로고    scopus 로고
    • Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2years
    • Jetsrisuparb, A., Komvilaisak, P., Wiangnon, S. & Jetsrisuparb, C. (2010) Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2years. Journal of Pediatric Hematology Oncology, 32, 400-403.
    • (2010) Journal of Pediatric Hematology Oncology , vol.32 , pp. 400-403
    • Jetsrisuparb, A.1    Komvilaisak, P.2    Wiangnon, S.3    Jetsrisuparb, C.4
  • 7
    • 56149116825 scopus 로고    scopus 로고
    • Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload
    • Otto-Duessel, M., Brewer, C., Gonzalez, I., Nick, H. & Wood, J.C. (2008) Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload. Acta Haematologica, 120, 123-128.
    • (2008) Acta Haematologica , vol.120 , pp. 123-128
    • Otto-Duessel, M.1    Brewer, C.2    Gonzalez, I.3    Nick, H.4    Wood, J.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.